LPAR5 promotes thyroid carcinoma cell proliferation and migration by activating class IA PI3K catalytic subunit p110β

Lysophosphatidic acid receptor 5 (LPAR5) is involved in mediating thyroid cancer progression, but the underlying mechanism needs to be further revealed. In this study, we confirmed that LPAR5 is upregulated in papillary thyroid carcinoma (PTC), especially in BRAF‐like PTC, by analyzing The Cancer Ge...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Sci
Main Authors: Zhao, Wei‐Jun, Zhu, Liu‐Lian, Yang, Wei‐Qiang, Xu, Shuai‐Jun, Chen, Jie, Ding, Xiao‐Fei, Liang, Yong, Chen, Guang
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2021
Subjects:
ORIGINAL ARTICLES
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8019227/
https://ncbi.nlm.nih.gov/pubmed/33540491
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14837
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items